All Stories

  1. Pro- and Anti-Inflammatory Cytokine Expression Levels in Macrophages; An Approach to Develop Indazolpyridin-methanones as Novel Inflammation Medication

    Article • Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, October 2020, Bentham Science Publishers

    Manikandan Alagumuthu, Napoleon Ayyakannu Arumugam

  2. Anticancer Effects of Novel Tetrahydro-Dimethyl-Xanthene-Diones

    Article • Anti-Cancer Agents in Medicinal Chemistry, July 2020, Bentham Science Publishers

    dr poonma p singh nigam, Manikandan Alagumuthu, Napoleon Ayyakannu Arumugam

  3. Synthesis of lead flavonoid analogues as Anti-inflammatory agents

    Article • Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, January 2020, Bentham Science Publishers

    DR SRINIVASAN KULANDAIVEL, Manikandan Alagumuthu, Kiruthiga Natarajan

  4. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking

    Article • Molecular Informatics, July 2018, Wiley

    Manikandan Alagumuthu

  5. Drug design and development

    Article • June 2018, Wiley

    Manikandan Alagumuthu

  6. Synthesis of Substituted Quinolinyl Ether-based Inhibitors of PI3K as Potential Anticancer Agents

    Article • Journal of Heterocyclic Chemistry, May 2018, Wiley

    Manikandan Alagumuthu

  7. Synthesis and Molecular Drug Efficacy of Indoline-based Dihydroxy-thiocarbamides: Inflammation Regulatory Property Unveiled over COX-2 Inhibition, Molecular Docking, and Cytotoxicity Prospects

    Article • Journal of Heterocyclic Chemistry, May 2018, Wiley

    Manikandan Alagumuthu

  8. Molecular Substantiation and Drug Efficacy of Relatively High Molecular Weight S-BINOLs; Appraised as Breast Cancer Medication and PI3Kinase Inhibitors

    Article • Journal of Heterocyclic Chemistry, April 2018, Wiley

    Manikandan Alagumuthu

  9. N-substituted hydroxynaphthalene imino-oxindole derivatives as new class of PI3-kinase inhibitor and breast cancer drug: Molecular validation and structure-activity relationship studies

    Article • Chemical Biology & Drug Design, September 2017, Wiley

    Manikandan Alagumuthu